Education
About Us
Working with TipRanks
Follow Us
Joint Corp (JYNT)
NASDAQ:JYNT
JYNT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.58 - $15.32
Previous CloseN/A
Volume11.07K
Average Volume (3M)72.85K
Market Cap
$177.51M
Enterprise Value$218.86M
Total Cash (Recent Filing)$21.92M
Total Debt (Recent Filing)$2.25M
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Aug 07, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding15,302,772
10 Day Avg. Volume34,229
30 Day Avg. Volume72,854
Financial Highlights & Ratios
PEG Ratio-2.44
Price to Book (P/B)31.85
Price to Sales (P/S)0.00
P/FCF Ratio137.23
Enterprise Value/Market Cap1.23
Enterprise Value/Revenue0.67
Enterprise Value/Gross Profit9.78
Enterprise Value/Ebitda8.98
Forecast
1Y Price Target
$15.50Price Target Upside33.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
Joint News
PremiumCompany Announcements
Joint Corp. Sells Clinics, Acquires Developer Rights
PremiumCompany Announcements
Joint Corp. Sells Clinics in Strategic Move
PremiumCompany Announcements
Joint Corp. Appoints New CFO Scott J. Bowman
PremiumCompany Announcements
Joint Corp. Appoints New Director and Chair
Bulls Say, Bears Say
Bulls Say
Digital StrategyThe Joint is advancing its digital strategy, with increased online scheduling capabilities and the launch of its first mobile app expected, which could improve the patient experience and drive repeat visits.
Financial PerformanceJYNT had $25.1M in cash and no debt, and it is expected to generate positive cash flows from continuing operations.
ProfitabilityThe strategic shift is anticipated to result in The Joint becoming an overall more profitable business with an improved margin structure.
Bears Say
Execution RisksExecution risks remain, as the company has yet to finalize the sale of a significant number of corporate-owned clinics.
Restructuring TimelineThe restructuring timeline remains uncertain, and near-term performance could be volatile.
Restructuring UncertaintyThe potential sale, relocation, or closure of company-owned clinics creates uncertainty.
Options Prices
Currently, No data available
---
Ownership Overview
1.83% Insiders
12.99% Mutual Funds
42.19% Other Institutional Investors
34.29% Public Companies and
Individual Investors
JYNT FAQ
What was Joint Corp’s price range in the past 12 months?
Joint Corp lowest stock price was $9.58 and its highest was $15.31 in the past 12 months.
What is Joint Corp’s market cap?
Joint Corp’s market cap is $177.51M.
When is Joint Corp’s upcoming earnings report date?
Joint Corp’s upcoming earnings report date is Aug 07, 2025 which is in 24 days.
How were Joint Corp’s earnings last quarter?
Joint Corp released its earnings results on May 08, 2025. The company reported -$0.03 earnings per share for the quarter, missing the consensus estimate of $0.002 by -$0.032.
Is Joint Corp overvalued?
According to Wall Street analysts Joint Corp’s price is currently Undervalued.
Does Joint Corp pay dividends?
Joint Corp does not currently pay dividends.
What is Joint Corp’s EPS estimate?
Joint Corp’s EPS estimate is -0.04.
How many shares outstanding does Joint Corp have?
Joint Corp has 15,302,772 shares outstanding.
What happened to Joint Corp’s price movement after its last earnings report?
Joint Corp reported an EPS of -$0.03 in its last earnings report, missing expectations of $0.002. Following the earnings report the stock price went down -5.128%.
Which hedge fund is a major shareholder of Joint Corp?
Currently, no hedge funds are holding shares in JYNT
Joint Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.50 (33.62% Upside)
$15.50 (33.62% Upside)
Blogger Sentiment
Neutral
JYNT Sentiment 50%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.95%
12-Months-Change
Fundamentals
Return on Equity
-27.25%
Trailing 12-Months
Asset Growth
-9.91%
Trailing 12-Months
Company Description
Joint Corp
The Joint Corp. (JYNT) is a prominent player in the healthcare sector, specifically focusing on providing chiropractic services. Established to offer a non-invasive, drug-free approach to pain management and wellness, The Joint Corp. operates a network of modern chiropractic clinics across the United States. The company's clinics provide a range of services aimed at improving patients' quality of life through regular chiropractic adjustments, focusing on spinal alignment and overall physical health.
JYNT Company Deck
JYNT Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While there was notable revenue growth and significant progress in franchise expansion, there were also challenges such as a decline in adjusted EBITDA, decreased sales in mature clinics, increased operational costs, and a decline in franchise license sales.Read More>JYNT Stock 12 Month Forecast
Average Price Target
$15.50
▲(33.62%Upside)